The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Suicide, suicidality and suicide prevention in affective disorders
Abstract
Objective: It is well known that functional psychiatric disorders are one of the main causes of suicidal behaviour. This paper discusses the epidemiology and risk factors of suicidal behaviour in affective disorders and goes on to describe the treatment and prevention of such suicidal behaviour. Method: A narrative overview of relevant epidemiological and drug studies. Results: About 60–70% of patients with acute depression experience suicidal ideas. There is a high incidence of suicide (10–15%) in depressive patients. Psychopharmacological treatment with antidepressants and/or mood stabilizers is the most successful approach to avoid the risk of suicidal behaviour. In addition, psychotherapeutic and psychosocial interventions are of importance. Conclusion: Suicidal behaviour and suicide must be considered when treating patients with affective disorders. The complex causation of suicidality has to be borne in mind when considering methods of suicide prevention. In order to obtain the best results, psychosocial, psychotherapeutic and psychopharmacological approaches should be combined, depending on the risk factors of each individual patient.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MDD is also associated with elevated risk of onset, persistence, and severity of a wide range of chronic physical disorders as well as with increased early mortality due to an even wider range of physical disorders and to suicide.”
From The Costs of Depression (2012) · cites this paper as [120]
In the citing paper
“MDD is associated with significantly elevated risk of early death.104, 106, 119 This is true partly because people with MDD have high suicide risk,120–122 but also because depression is associated with elevated risk of the many types of disorders noted above. MDD is also associated with elevated mortality risk among people with certain kinds of disorders as part of a larger pattern of associations”
From The Costs of Depression (2012) · cites this paper as [120]
Citations
Cites
Suicide as an outcome for mental disorders: A meta-analysis
Harris, E. C., & Barraclough, B. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.170.3.205 · Cited by 2,589
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881
Suicide and Primary Affective Disorders
Guzé, S. B., & Robins, E. (1970) · The British Journal of Psychiatry · doi:10.1192/bjp.117.539.437 · Cited by 724
Monoamine Metabolites in CSF and Suicidal Behavior
Träskman, L. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780310031002 · Cited by 692
Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia
Inskip, H., Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.1.35 · Cited by 579
Crow, T. J. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.4.531-a · Cited by 555
Emergence of intense suicidal preoccupation during fluoxetine treatment
Teicher, M. H., Glod, C. A., & Cole, J. O. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.2.207 · Cited by 534
Chen, Y.-W., & Dilsaver, S. C. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00295-2 · Cited by 509
Thompson, C., Kinmonth, A., Stevens, L., Pevele, R., Stevens, A., Ostler, K., Pickering, R., Baker, N., Henson, A., Preece, J., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)03171-2 · Cited by 489
Lépine, J., Gastpar, M., Mendlewicz, J., & Tylee, A. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199701000-00003 · Cited by 483
Research works printed but not linked: 4
- WHO. Euro multicentre study on parasuicide, 1999, Facts and figures
- SacchettiE VitaA GuarneriL CornacchiaM.The effectiveness of fluoxetine clomipramine nortriptyline and desipramine in major depressives with suicidal behaviour: preliminary findings. In:CassanoGB AkiskalHS eds.Serotonin‐related psychiatric syndromes: clinical and therapeutic links. Royal Society of Medicine Services International Congress and Symposium Series 165 1991:105–113.
- Baldessarini RJ, 1999, Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic‐depressive disorders, J Clin Psychiatry, 60, 77
- Motto J, 1981, Depression et suicide, 148
Cited by
Sorted by citations
The Epidemiology of Depression Across Cultures
Kessler, R. C., & Bromet, E. J. (2013) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031912-114409 · Cited by 2,657
Kessler, R. C. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.11.005 · Cited by 871
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
Self-citationRisk factors for suicidality in Europe: Results from the ESEMED study
Bernal, M., Haro, J. M., Bernert, S., Brugha, T., de Graaf, R., Bruffaerts, R., Lépine, J. P., de Girolamo, G., Vilagut, G., Gasquet, I., et al. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.09.018 · Cited by 565
Bauer, M., Bschor, T., Pfennig, A., Whybrow, P. C., Angst, J., Versiani, M., Möller, H., & WFSBP Task Force on Unipolar Depres (2007) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701227829 · Cited by 483
Self-citation
Metadata
- Authors
- Möller, H. J.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- Corresponding author
- Möller, H. J.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2003-09-04
- Volume
- 108
- Issue
- s418
- Pages
- 73-80
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W1974591192
- Cited by
- 127
- References
- 82
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 6 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 5 · 2016: 12 · 2015: 7 · 2014: 9 · 2013: 8 · 2012: 4
- FWCI
- 8.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Acta Psychiatrica Scandinavica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- suicide, suicidality, suicide prevention, mood disorders, depression, suicidal ideation, suicide risk factors, antidepressants, mood stabilizers, psychosocial interventions, psychotherapy, combination therapy
- MeSH terms
- Suicide Prevention, Affect, Antidepressive Agents, Clinical Trials as Topic, Humans, Risk Factors, Suicide, Attempted, Incidence, Epidemiologic Studies, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
